Related Experiment Videos

Nomogram for predicting 6-month BMIZ changes in children with Crohn's disease: a single-center retrospective study

Yifei Zhang1, Peilin Wu1, Xilin Peng1

  • 1Department of Pediatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

BMC Pediatrics
|July 3, 2026
PubMed

Insights

Perianal disease (PD) in pediatric Crohn's disease (CD) patients significantly hinders short-term nutritional recovery. A new nomogram incorporating PD and other markers aids early risk identification for better management.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Nutritional Science

Background:

  • Perianal disease (PD) is a severe manifestation in pediatric Crohn's disease (CD).
  • The impact of PD on short-term nutritional recovery in pediatric CD is not well understood.
  • Early identification of nutritional risks is crucial for managing pediatric CD.

Purpose of the Study:

  • To assess the independent effect of PD on the 6-month Body Mass Index Z-score (BMIZ) trajectory in pediatric CD patients.
  • To develop a predictive nomogram for early risk stratification of nutritional recovery in pediatric CD.
  • To evaluate the clinical utility of the nomogram for identifying patients at risk of inadequate nutritional recovery.

Main Methods:

  • Retrospective cohort study of 51 pediatric CD patients with PD (n=29) and without PD (n=22).
  • Linear mixed models (LMM) analyzed BMIZ trajectories over 6 months.
  • LASSO regression identified predictors for a nomogram, validated by bootstrap resampling and decision curve analysis (DCA).

Main Results:

  • PD significantly reduced the slope of BMIZ recovery (β = -0.085, P = 0.010) after adjusting for covariates.
  • Key predictors identified: PD, fecal occult blood test (FOBT), biologic therapy, ESR, Hb, and 25(OH)D3.
  • The nomogram showed good predictive performance (R² = 0.51) and clinical utility for predicting inadequate nutritional recovery (ΔBMIZ ≤ 0.40).

Conclusions:

  • Perianal disease is independently linked to suboptimal short-term nutritional recovery in pediatric CD.
  • The developed nomogram integrates clinical, inflammatory, and nutritional factors for risk stratification.
  • This tool can aid in early identification of high-risk patients, guiding individualized nutritional monitoring and treatment planning.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...